Literature DB >> 7679487

Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum.

D R Powell1, F Liu, B Baker, P D Lee, C W Belsha, E D Brewer, R L Hintz.   

Abstract

IGF-binding protein-3 (IGFBP-3), usually found as glycosylated 41- and 38-kD forms, is the major serum IGFBP during extrauterine life. In normal serum IGFBP-3 binds one IGF peptide and one acid-labile (alpha) subunit in a high-molecular-weight (MW) complex of 150 kD. By RIA, an excess of IGFBP-3 is present in chronic renal failure (CRF) serum, where it reportedly accumulates at low MW (25-55 kD) rather than as part of the 150-kD complex. To further evaluate IGFBP-3 forms in CRF, sera were obtained from seven healthy adolescents and seven adolescents with CRF. By RIA, IGFBP-3 levels were higher in CRF than normal sera (15.4 +/- 2.2 versus 10.1 +/- 2.1 micrograms/mL). High-MW (150-kD) fractions of CRF and normal sera, obtained by neutral size-exclusion chromatography, had equal amounts of IGFBP-3 by RIA. However, a second RIA peak of IGFBP-3, present in low-MW (35-kD) fractions of CRF but not normal sera, could account for the higher IGFBP-3 levels of CRF serum. [125I]IGF ligand blots of whole serum and serum fractions, either with or without prior precipitation by IGFBP-3 antiserum, found levels of 41- and 38-kD IGFBP-3 forms to be similar between CRF and normal whole sera and located these forms in the high-MW (150-kD) fractions of CRF and normal sera.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679487     DOI: 10.1203/00006450-199302000-00011

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis.

Authors:  Tetyana L Vasylyeva; Xiaoyan Chen; Robert J Ferry
Journal:  Growth Horm IGF Res       Date:  2005-03-23       Impact factor: 2.372

Review 2.  Growth hormone/insulin-like growth factor system in children with chronic renal failure.

Authors:  Burkhard Tönshoff; Daniela Kiepe; Sonia Ciarmatori
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

3.  Evaluation of clinical and laboratory parameters during 2 years of growth hormone treatment in prepubertal children with chronic renal failure.

Authors:  D Simon; M Neol; P Brun; D Porquet; P Rocchicioli; C Loirat; P Czernichow
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

Review 4.  Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure.

Authors:  D R Powell; F Liu; B K Baker; P D Lee; R L Hintz
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 5.  The effects of recombinant human erythropoietin on growth and nutritional status.

Authors:  K Jabs
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

6.  Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease.

Authors:  B Tönshoff; W F Blum; O Mehls
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.